Search - tctmd.com

Displaying 281 - 298 of 298

Sort: Relevancy | Date

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

News Daily News

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

July 10, 2012

News Daily News

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

July 10, 2012

News Daily News

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

June 26, 2012

News Daily News

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

June 26, 2012

News Daily News

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Caitlin E. Cox

June 07, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Daily News

Ticagrelor Gains FDA Approval for Use in ACS

Caitlin E. Cox

July 22, 2011

News Daily News

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

June 15, 2011

News Daily News

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Jason Kahn

June 13, 2011

News Daily News

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

June 09, 2011

News Daily News

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

May 02, 2011

News Daily News

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

L.A. McKeown

April 15, 2011

News Daily News

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

Caitlin E. Cox

January 25, 2011

News Daily News

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

L.A. McKeown

January 03, 2011

CME

Advertisement

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Ticagrelor Provides More Potent Platelet Inhibition Than Prasugrel

El Ticagrelor ofrece una Inhibición Plaquetaria Más Potente que el Prasugrel

Subanálisis del PLATO: El Ticagrelor es Rentable en Pacientes con SCA

PLATO Subanalysis: Ticagrelor Cost-Effective in ACS Patients

La Opción Antitrombótica durante una PCI Influye en los Resultados de los Malos Respondedores al Clopidogrel

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

ESC Congress 2011: Drugs, Devices Work Together

Ticagrelor Gains FDA Approval for Use in ACS

Study Applies Standardized Bleeding Definition to Disparate Antiplatelet Trials

HORIZONS-AMI Published: Bivalirudin, Taxus Stay Strong at 3 Years

Predictors of Serious Bleeding in ACS Patients from TRITON-TIMI Identified

PLATO Substudy: Excess Arrhythmias with Ticagrelor Have No Clinical Impact

Antithrombin Plus Preloading with Clopidogrel May Reduce Stent Thrombosis

Letters to Lancet Take on PCI Substudy of CURRENT-OASIS 7

PLATO CABG Cohort: Ticagrelor Cuts Total and CV Mortality in Half

A New Era of P2Y12 Inhibitors: Transitioning from Intravenous to Oral Platelet Inhibitors after PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content